Loading clinical trials...
Loading clinical trials...
INSPiRE-ICU 1 & 2: A Pooled Analysis of Long-Term Outcomes at 3 and 6 Months After Inhaled Isoflurane Delivered Via the Sedaconda ACD-S Compared to Intravenous Propofol for Sedation of Mechanically Ventilated Intensive Care Unit Adult Patients
Conditions
Interventions
Inhaled isoflurane administered by Sedaconda ACD-S
Intravenous infusion of propofol
Locations
1
United States
The Critical Illness, Brain Dysfunction and Survivorship (CIBS) Center
Nashville, Tennessee, United States
Start Date
April 22, 2022
Primary Completion Date
November 14, 2024
Completion Date
January 30, 2025
Last Updated
February 5, 2025
NCT07440342
NCT06436638
NCT07461376
NCT07269808
NCT07000526
NCT07413848
Lead Sponsor
Sedana Medical
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions